Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Triphasic norgestimate-ethinyl estradiol for treating dysfunctional uterine bleeding.

A Davis1, A Godwin, J Lippman

  • 1Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA.

Obstetrics and Gynecology
|November 21, 2000
PubMed
Summary

A triphasic oral contraceptive containing norgestimate and ethinyl estradiol effectively treats dysfunctional uterine bleeding (DUB). This treatment improved abnormal bleeding patterns and physical functioning compared to placebo.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rubyspira, new genus and two new species of bone-eating deep-sea snails with ancient habits.

The Biological bulletin·2010
Same author

Intra-uterine Aspiration.

British medical journal·2010
Same author

Dicoumarin in Puerperal Thrombosis.

British medical journal·2010
Same author

A simple double-focusing electrostatic ion beam deflector.

The Review of scientific instruments·2010
Same author

Prevalence of Cysticercus bovis in Australian cattle.

Australian veterinary journal·2010
Same author

Induction of immune tolerance using rituximab in a child with severe haemophilia B with inhibitors and anaphylaxis to factor IX.

Haemophilia : the official journal of the World Federation of Hemophilia·2010

Area of Science:

  • Gynecology
  • Reproductive Health
  • Pharmacology

Background:

  • Dysfunctional uterine bleeding (DUB) encompasses various abnormal uterine bleeding patterns.
  • Metrorrhagia, menometrorrhagia, oligomenorrhea, and polymenorrhea are common DUB types.
  • Effective management of DUB is crucial for improving women's quality of life.

Purpose of the Study:

  • To evaluate the efficacy of a triphasic oral contraceptive (OC) containing norgestimate and ethinyl estradiol (E2).
  • To compare this OC's effectiveness against a placebo in treating specific DUB types.
  • To assess the impact on bleeding patterns and quality of life.

Main Methods:

  • A multicenter, randomized, double-masked study involving 201 women aged 15-50 with DUB.
  • Participants received either triphasic norgestimate-ethinyl E2 or a placebo for three 28-day cycles.

Related Experiment Videos

  • Efficacy was measured by investigator/subject assessments of DUB resolution, bleeding patterns, and quality of life changes.

    • Main Results:

    • Over 80% of subjects on the triphasic OC showed improved bleeding patterns versus fewer than 50% on placebo (P <.001).
    • Significantly fewer subjects on the triphasic OC reported abnormal bleeding patterns (P <.001).
    • Improvements in physical functioning were significantly greater in the triphasic OC group.

    Conclusions:

    • The triphasic combination of norgestimate and ethinyl E2 is an effective treatment for DUB.
    • This OC demonstrates significant benefits in managing metrorrhagic, menometrorrhagic, oligomenorrheic, and polymenorrheic bleeding.
    • The treatment positively impacts physical functioning, suggesting improved quality of life.